Mihaly G W, Marino A T, Webster L K, Jones D B, Louis W J, Smallwood R A
Br Med J (Clin Res Ed). 1982 Oct 9;285(6347):998-9. doi: 10.1136/bmj.285.6347.998.
To investigate the effect of antacid on the bioavailability and disposition of ranitidine six healthy volunteers were studied on two occasions one week apart. In the first study the received ranitidine 150 mg with 60 ml water, and in the second study they received ranitidine 150 mg plus 30 ml of an aluminium/magnesium hydroxide mixture (Mylanta II) and 30 ml water. Giving antacid reduced both the maximum plasma ranitidine concentration and the area under the curve by one-third; elimination of the drug was not changed. Thus giving a high dose of antacid significantly diminished the bioavailability of ranitidine.
为研究抗酸剂对雷尼替丁生物利用度及处置的影响,对6名健康志愿者进行了研究,两次研究间隔一周时间。在首次研究中,他们服用150毫克雷尼替丁加60毫升水,在第二次研究中,他们服用150毫克雷尼替丁加30毫升氢氧化铝/氢氧化镁混合物(胃仙-U)和30毫升水。服用抗酸剂使雷尼替丁的血浆最大浓度和曲线下面积均降低了三分之一;药物的消除未发生改变。因此,服用高剂量抗酸剂显著降低了雷尼替丁的生物利用度。